Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study

Apr-22

Nephrology Pharmacoepidemiology Rheumatology

AUTHORS : Prof Guanghua Lei, Department of Orthopaedics, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China – Email: lei_guanghua@csu.edu.cn – Profile: https://www.xiangya.com.cn/english/ezj_info.aspx?id=134&chn=3420 OR Dr Yuqing Zhang, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA – Email: yzhang108@mgh.harvard.edu – Profile: https://advances.massgeneral.org/contributors/contributor.aspx?id=1566

JOURNAL : Annals of Internal Medicine

REFERENCE: 175(4):461-470

DOI : 10.7326/M21-2347

Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study